SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VD's Model Portfolio & Discussion Thread

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: biowa who wrote (1240)6/18/1997 11:31:00 AM
From: Andrew H   of 9719
 
Good news for CYTO holders--an important new hire. BIOWA--have you ever heard of her? Can you get any info on her? Vector, have you ever heard of her? I hear she is well known and respected in the financial community, so someone should have heard of her or be able to find out something about her.The rest of the release can be found on Yahoo:

CYTOGEN Announces Management Additions

PRINCETON, N.J., June 18 /PRNewswire/ -- CYTOGEN Corporation (Nasdaq:CYTO) announced the addition of two new members to its management team. Lynne Pauls Baron has been appointed Vice President, Finance and Communications. Donald F. Crane, Jr. has been appointed Vice President, General Counsel and Corporate Secretary.

Both will report directly to CYTOGEN's Chairman of the Board, President and Chief Executive Officer, Thomas J. McKearn.

In her new capacity, Ms. Baron will oversee the financial, investor relations and communications functions of the Company. Most recently Ms. Baron was Managing Principal of Prescription Capital, Inc., a corporate finance consulting firm. At Prescription Capital she managed financial strategies for early stage companies, corporate partnerships, institutional investor strategies and financings for a variety of businesses, including biotechnology companies. Prior to this, Ms. Baron was an equities research analyst for several major institutional brokerage firms, following multinational drug companies and selected biotechnology companies. She has also held management positions with Pfizer Pharmaceuticals and Eli Lilly and Company. Ms. Baron holds a Master of Business Administration degree with honors from Indiana University, Bloomington.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext